156 related articles for article (PubMed ID: 18434144)
1. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs).
Milite C; Castellano S; Benedetti R; Tosco A; Ciliberti C; Vicidomini C; Boully L; Franci G; Altucci L; Mai A; Sbardella G
Bioorg Med Chem; 2011 Jun; 19(12):3690-701. PubMed ID: 21292492
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the binding mode and mechanistic insights of pentadecylidenemalonate (1b) as activator of histone acetyltransferase PCAF.
Suryanarayanan V; Singh SK
J Biomol Struct Dyn; 2019 Jun; 37(9):2296-2309. PubMed ID: 30044210
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities.
Souto JA; Conte M; Alvarez R; Nebbioso A; Carafa V; Altucci L; de Lera AR
ChemMedChem; 2008 Sep; 3(9):1435-42. PubMed ID: 18537201
[TBL] [Abstract][Full Text] [Related]
5. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
6. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
7. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.
Stimson L; Rowlands MG; Newbatt YM; Smith NF; Raynaud FI; Rogers P; Bavetsias V; Gorsuch S; Jarman M; Bannister A; Kouzarides T; McDonald E; Workman P; Aherne GW
Mol Cancer Ther; 2005 Oct; 4(10):1521-32. PubMed ID: 16227401
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
[TBL] [Abstract][Full Text] [Related]
9. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
Bowers EM; Yan G; Mukherjee C; Orry A; Wang L; Holbert MA; Crump NT; Hazzalin CA; Liszczak G; Yuan H; Larocca C; Saldanha SA; Abagyan R; Sun Y; Meyers DJ; Marmorstein R; Mahadevan LC; Alani RM; Cole PA
Chem Biol; 2010 May; 17(5):471-82. PubMed ID: 20534345
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties.
Mai A; Rotili D; Tarantino D; Ornaghi P; Tosi F; Vicidomini C; Sbardella G; Nebbioso A; Miceli M; Altucci L; Filetici P
J Med Chem; 2006 Nov; 49(23):6897-907. PubMed ID: 17154519
[TBL] [Abstract][Full Text] [Related]
11. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PCAF histone acetyltransferase and cytotoxic effect of N-acylanthranilic acids.
Park WJ; Ma E
Arch Pharm Res; 2012 Aug; 35(8):1379-86. PubMed ID: 22941480
[TBL] [Abstract][Full Text] [Related]
14. Small molecule modulators of histone acetyltransferase p300.
Balasubramanyam K; Swaminathan V; Ranganathan A; Kundu TK
J Biol Chem; 2003 May; 278(21):19134-40. PubMed ID: 12624111
[TBL] [Abstract][Full Text] [Related]
15. Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
Lu W; Xiong H; Chen Y; Wang C; Zhang H; Xu P; Han J; Xiao S; Ding H; Chen Z; Lu T; Wang J; Zhang Y; Yue L; Liu YC; Zhang C; Yang Y; Jiang H; Chen K; Zhou B; Luo C
Bioorg Med Chem; 2018 Nov; 26(20):5397-5407. PubMed ID: 30297119
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel inhibitors of histone acetyltransferases.
Eliseeva ED; Valkov V; Jung M; Jung MO
Mol Cancer Ther; 2007 Sep; 6(9):2391-8. PubMed ID: 17876038
[TBL] [Abstract][Full Text] [Related]
17. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
[TBL] [Abstract][Full Text] [Related]
18. Curcumin is an inhibitor of p300 histone acetylatransferase.
Marcu MG; Jung YJ; Lee S; Chung EJ; Lee MJ; Trepel J; Neckers L
Med Chem; 2006 Mar; 2(2):169-74. PubMed ID: 16787365
[TBL] [Abstract][Full Text] [Related]
19. 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.
Ghizzoni M; Wu J; Gao T; Haisma HJ; Dekker FJ; George Zheng Y
Eur J Med Chem; 2012 Jan; 47(1):337-44. PubMed ID: 22100137
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication.
Mantelingu K; Reddy BA; Swaminathan V; Kishore AH; Siddappa NB; Kumar GV; Nagashankar G; Natesh N; Roy S; Sadhale PP; Ranga U; Narayana C; Kundu TK
Chem Biol; 2007 Jun; 14(6):645-57. PubMed ID: 17584612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
